Abstract
Crohn’s disease (CD) is a lifelong, chronic, progressive inflammatory disease of the gastrointestinal tract associated with diarrhea, abdominal pain, bloody stool, and often perianal fistulae. Inflammation throughout the small and large bowels causes irreversible bowel damage, such as strictures, fistulae, and abscesses, despite achieving clinical remission. To optimize therapy for CD, it is necessary to monitor disease activity and evaluate therapeutic interventions. Evaluations based on clinical activity alone are not sufficient, and frequent imaging examinations, particularly of the small bowel, are important. In recent years, many new imaging modalities have been developed, such as video capsule endoscopy (VCE), balloon-assisted enteroscopy (BAE), ultrasonography (US), computed tomography enterography (CTE), and magnetic resonance enterography/enterocolonography (MRE/MREC). A suitable imaging modality should be reproducible, well-tolerated, safe, and free of ionizing radiation because CD is a lifelong disease. MRE and MREC are cross-sectional imaging techniques used to investigate not only extraluminal abnormalities but also intraluminal changes. Recent advances have enabled the use of MRI to assess bowel disorders with high levels of sensitivity, specificity, and accuracy. MRI can evaluate not only intrabowel lesions but also extrabowel lesions, including abdominal abscesses and perianal lesions while eliminating the problem of overlapping bowel loops. Therefore, MRI could potentially be used to evaluate overall CD activity without causing radiation exposure. MRE and MREC are, therefore, suitable first-line imaging modalities for the assessment of CD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pariente B, Cosnes J, Danese S, et al. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis. 2011;17:1415–22.
Cosnes J, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.
Peyrin-Biroulet L, Loftus Jr EV, Colombel JF, et al. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–97.
Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut. 2007;56:453–5.
Pariente B, Mary JY, Danese S, Chowers Y, et al. Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology. 2015;148:52–63.e3.
Travis SP, Stange EF, Le’mann M, et al. European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. Gut. 2006;55(Suppl 1):i16–35.
Allen PB, De Cruz P, Lee WK, et al. Noninvasive imaging of the small bowel in Crohn's disease: the final frontier. Inflamm Bowel Dis. 2011;17:1987–99.
Dionisio PM, Gurudu SR, Leighton JA, et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Am J Gastroenterol. 2010;105:1240–8.
Cheifetz AS, Kornbluth AA, Legnani P, et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn’s disease. Am J Gastroenterol. 2006;101:2218–22.
Fraquelli M, Colli A, Casazza G, et al. Role of US in detection of Crohn disease: meta-analysis. Radiology. 2005;236:85–101.
Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–84.
Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 2013;21:346.
Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103:2015–22.
Fiorino G, Bonifacio C, Malesci A, et al. MRI in Crohn's disease–current and future clinical applications. Nat Rev Gastroenterol Hepatol. 2012;9:23–31.
Amitai MM, Ben-Horin S, Eliakim R, et al. Magnetic resonance enterography in Crohn's disease: a guide to common imaging manifestations for the IBD physician. J Crohns Colitis. 2012;7:603–15.
Zimmermann EM, Al-Hawary MM. MRI of the small bowel in patients with Crohn's disease. Curr Opin Gastroenterol. 2011;27:132–8.
Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis. 2011;17:1073–80.
Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247:64–79.
Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7–27.
Masseli G, Gualdi G. MR imaging of the small bowel. Radiology. 2012;264:333–48.
Rimola J, Rodriguez S, García-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut. 2009;58:1113–20.
Schreyer AG, Rath HC, Kikinis R, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut. 2005;54:250–6.
Oussalah A, Laurent V, Bruot O, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut. 2010;59:1056–65.
Hyun SB, Kitazume Y, Nagahori M, et al. Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn's disease. Inflamm Bowel Dis. 2011;17:1063–72.
Takenaka K, Ohtsuka K, Fujii T, et al. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn’s disease. Gastroenterology. 2014;147:334–42.
Fujii T, Naganuma M, Kitazume Y, et al. Advancing MR imaging in Crohn’s disease. Digestion. 2014;89:24–30.
Rimola J, Ordás I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis. 2011;17:1759–68.
Rimola J, Ordás I, Rodriguez S, et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology. 2014;146:374.e1–82.e1.
Takenaka K, Ohtsuka K, Kitazume Y, et al. Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn’s disease. Inflamm Bowel Dis. 2015;21:1832–8.
Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–40.
Sailer J, Peloschek P, Reinisch W, et al. Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol. 2008;18:2512–21.
Koilakou S, Sailer J, Peloschek P, et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn’s disease after ileocolic resection. Inflamm Bowel Dis. 2010;16:198–203.
Fujii T, Naganuma M, Kitazume Y, et al. 556 MR enterocolonography is useful to predict clinical recurrence of Crohn’s disease and identify patients who need more aggressive treatment. Gastroenterology. 2013;144:S-102.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Japan
About this chapter
Cite this chapter
Fujii, T. (2018). Current Progress of Endoscopy in Inflammatory Bowel Disease: MR Enterography. In: Hibi, T., Hisamatsu, T., Kobayashi, T. (eds) Advances in Endoscopy in Inflammatory Bowel Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56018-0_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-56018-0_6
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56016-6
Online ISBN: 978-4-431-56018-0
eBook Packages: MedicineMedicine (R0)